Ion Therapy Patient Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorEBG MedAustron GmbH
About this trial
The purpose of the study is the prospective and standardized data collection of patients treated with ion therapy at MedAustron.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with tumor disease treated with ion beam therapy at MedAustron
Signed informed consent form
Disqualifiers
Comorbidities endangering treatment delivery or study compliance
Trial population
Patients treated with ion beam therapy at MedAustron
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Protons and Carbon Ions
Radiation
Treatment groups
2,800 Participants
are divided into 1 treatment groupGroup A: Ion beam therapy1 intervention
Trial outcomes
Primary outcomes
1
Therapy response
Therapy Response according to RECIST Version 1.1
Time frame
10 years2
Overall survival
Time frame
10 years3
Progression-free survival
Time frame
10 years4
Local progression-free survival
Time frame
10 yearsSecondary outcomes
1
EORTC-QLQ-C30
Patient-reported quality of life
Time frame
Through study completion, at 3, 5, and 10 years2
EORTC-QLQ-BN20
Patient-reported quality of life for brain cancer patients
Time frame
Through study completion, at 3, 5, and 10 years3
EORTC-QLQ-PR25
Patient-reported quality of life for prostate cancer patients
Time frame
Through study completion, at 3, 5, and 10 years4
Neurocognitive test battery
Change in cognition from baseline to endpoint as measured by standardized subtests of test battery
Time frame
Through study completion, at 3, 5, and 10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov